198 related articles for article (PubMed ID: 8049655)
1. Bone marrow necrosis following ALL-trans retinoic acid therapy for acute promyelocytic leukaemia.
Dreosti LM; Bezwoda W; Gunter K
Leuk Lymphoma; 1994 Apr; 13(3-4):353-6. PubMed ID: 8049655
[TBL] [Abstract][Full Text] [Related]
2. Bone marrow necrosis in two patients with acute promyelocytic leukemia during treatment with all-trans retinoic acid.
Limentani SA; Pretell JO; Potter D; DuBois JS; Daoust PR; Spieler PS; Miller KB
Am J Hematol; 1994 Sep; 47(1):50-5. PubMed ID: 8042616
[TBL] [Abstract][Full Text] [Related]
3. Early mortality and the retinoic acid syndrome in acute promyelocytic leukemia: impact of leukocytosis, low-dose chemotherapy, PMN/RAR-alpha isoform, and CD13 expression in patients treated with all-trans retinoic acid.
Vahdat L; Maslak P; Miller WH; Eardley A; Heller G; Scheinberg DA; Warrell RP
Blood; 1994 Dec; 84(11):3843-9. PubMed ID: 7949141
[TBL] [Abstract][Full Text] [Related]
4. Pre-treatment with all-trans retinoic acid accelerates polymorphonuclear recovery after chemotherapy in patients with acute promyelocytic leukemia.
Visani G; Tosi P; Cenacchi A; Manfroi S; Gamberi B; Ottaviani E; Tura S
Leuk Lymphoma; 1994 Sep; 15(1-2):143-7. PubMed ID: 7858492
[TBL] [Abstract][Full Text] [Related]
5. Treatment of newly diagnosed acute promyelocytic leukemia (APL) by all transretinoic acid (ATRA) combined with chemotherapy: The European experience. European APL Group.
Fenaux P; Chastang C; Chomienne C; Castaigne S; Sanz M; Link H; Löwenberg B; Fey M; Archim-Baud E; Degos L
Leuk Lymphoma; 1995 Feb; 16(5-6):431-7. PubMed ID: 7787753
[TBL] [Abstract][Full Text] [Related]
6. Disappearance of PML/RAR alpha acute promyelocytic leukemia-associated transcript during consolidation chemotherapy.
Martinelli G; Ottaviani E; Testoni N; Visani G; Diverio D; D'Elia G; Mandelli F; Tura S
Haematologica; 1998 Nov; 83(11):985-8. PubMed ID: 9864917
[TBL] [Abstract][Full Text] [Related]
7. All-trans retinoic acid in the treatment of acute promyelocytic leukaemia.
White KL; Wiley JS; Frost T; McKendrick JJ; Hermann RP; Seldon M; Enno A; Bell R; Bunce I; Taylor K
Aust N Z J Med; 1992 Oct; 22(5):449-54. PubMed ID: 1445034
[TBL] [Abstract][Full Text] [Related]
8. [Complete remission in acute promyelocytic leukemia. The advantages of all-trans-retinoic acid compared to conventional chemotherapy].
Lengfelder E; Simon M; Haase D; Hild F; Hehlmann R
Dtsch Med Wochenschr; 1994 Aug; 119(34-35):1143-50. PubMed ID: 8076501
[TBL] [Abstract][Full Text] [Related]
9. [Effect of all-trans retinoic acid on the newly diagnosed acute promyelocytic leukaemia: our experience].
Rolovitsh Z; Cholovitsh M; Elezovitsh I; Vidovitsh A; Radoshevitsh-Radojkovitsh N; Boshkovitsh D; Novak A; Basara N
Srp Arh Celok Lek; 1995; 123(11-12):279-85. PubMed ID: 16296239
[TBL] [Abstract][Full Text] [Related]
10. Reversible bone marrow necrosis after all-trans retinoic acid induction therapy for acute promyelocytic leukaemia.
Lakhwani S; Raya JM; González-Brito G; Álvarez-Argüelles H; Brito ML; Hernández-Nieto L
Pathology; 2011 Aug; 43(5):515-7. PubMed ID: 21753723
[No Abstract] [Full Text] [Related]
11. Treatment of acute promyelocytic leukaemia relapsing after allogeneic bone marrow transplantation with all-trans-retinoic acid: suppression of the leukaemic clone.
Bashford J; Szer J; Wiley JS; Buckley M; Garson OM; Van der Weyden MB
Br J Haematol; 1991 Oct; 79(2):331-4. PubMed ID: 1958492
[TBL] [Abstract][Full Text] [Related]
12. Brief report: severe symptoms of hyperhistaminemia after the treatment of acute promyelocytic leukemia with tretinoin (all-trans-retinoic acid).
Koike T; Tatewaki W; Aoki A; Yoshimoto H; Yagisawa K; Hashimoto S; Furukawa T; Saitoh H; Takahashi M; Yang LB
N Engl J Med; 1992 Aug; 327(6):385-7. PubMed ID: 1625712
[No Abstract] [Full Text] [Related]
13. The "retinoic acid syndrome" in acute promyelocytic leukemia.
Frankel SR; Eardley A; Lauwers G; Weiss M; Warrell RP
Ann Intern Med; 1992 Aug; 117(4):292-6. PubMed ID: 1637024
[TBL] [Abstract][Full Text] [Related]
14. [Induction of hematologic remission in a patient with acute promyelocytic leukemia through the therapeutic use of trans-retinoic acid].
Skotnicki AB; Stoch A; Sacha T; Nowak WS
Acta Haematol Pol; 1994; 25(1):69-74. PubMed ID: 8209619
[TBL] [Abstract][Full Text] [Related]
15. Exacerbation of coagulopathy with concurrent bone marrow necrosis, hepatic and renal dysfunction secondary to all-trans retinoic acid therapy for acute promyelocytic leukemia.
Cull GM; Eikelboom JW; Cannell PK
Hematol Oncol; 1997 Feb; 15(1):13-7. PubMed ID: 9378467
[TBL] [Abstract][Full Text] [Related]
16. Sequential targeted therapy for relapsed acute promyelocytic leukemia with all-trans retinoic acid and anti-CD33 monoclonal antibody M195.
Jurcic JG; Caron PC; Miller WH; Yao TJ; Maslak P; Finn RD; Larson SM; Warrell RP; Scheinberg DA
Leukemia; 1995 Feb; 9(2):244-8. PubMed ID: 7869759
[TBL] [Abstract][Full Text] [Related]
17. [Fatal side-effects of all-trans retinoic acid in the treatment of acute promyelocytic leukemia].
Yang J; Han Z; Pei M; Xiao N
Hunan Yi Ke Da Xue Xue Bao; 1999; 24(3):293-5. PubMed ID: 12016812
[TBL] [Abstract][Full Text] [Related]
18. [Role of retinoic acid in the treatment of acute promyelocytic leukemia].
Gutiérrez de Guzmán J; Kantarjian H
Sangre (Barc); 1993 Oct; 38(5):375-8. PubMed ID: 8140499
[No Abstract] [Full Text] [Related]
19. Differentiation of extramedullary acute promyelocytic leukemia by all-trans-retinoic acid.
Lederman CA; Weisberger J; Seiter K; Feldman EJ
Leuk Lymphoma; 1995 Jun; 18(1-2):189-93. PubMed ID: 8580825
[TBL] [Abstract][Full Text] [Related]
20. Pulmonary embolism and thrombotic thrombocytopenic purpura in acute promyelocytic leukemia treated with all-trans retinoic acid.
Fujita H; Takemura S; Hyo R; Tanaka M; Koharazawa H; Fujisawa S; Kanamori H; Ishigatsubo Y
Leuk Lymphoma; 2003 Sep; 44(9):1627-9. PubMed ID: 14565670
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
